Record Information |
---|
Version | 2.0 |
---|
Created at | 2005-11-16 15:48:42 UTC |
---|
Updated at | 2021-10-07 20:39:59 UTC |
---|
NP-MRD ID | NP0000510 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Salicyluric acid |
---|
Description | Salicyluric acid is an aryl glycine conjugate formed by the body to eliminate excess salicylates, including aspirin. Aspirin is rapidly hydrolysed to salicylic acid which is further metabolized to various compounds, including salicyluric acid (SU) as well as various acyl and phenolic glucuronides, and hydroxylated metabolites. SU is the major metabolite of SA excreted in urine and it is present in the urine of people who have not taken salicylate drugs, although it has no anti-inflammatory effects in humans or in animals. More salicyluric acid (SU) is excreted in the urine of vegetarians than in non-vegetarians, primarily because fruits and vegetables are important sources of dietary salicylates. However, significantly less (10-15X) SU is excreted by vegetarians than individuals taking low-dose aspirin (PMID: 12944546 ). The induction of the salicyluric acid formation is one of the saturable pathways of salicylate elimination. The formation of the methyl ester of salicyluric acid is observed during the quantitation of salicyluric acid and other salicylate metabolites in urine by high-pressure liquid chromatography. This methyl ester formation causes artificially low values for salicyluric acid and high values for salicylic acid. (PMID: 6101164 , 6857178 ). |
---|
Structure | OC(=O)CNC(=O)C1=C(O)C=CC=C1 InChI=1S/C9H9NO4/c11-7-4-2-1-3-6(7)9(14)10-5-8(12)13/h1-4,11H,5H2,(H,10,14)(H,12,13) |
---|
Synonyms | Value | Source |
---|
N-(2-Hydroxybenzoyl)-glycine | ChEBI | N-Salicyloylglycine | ChEBI | O-Hydroxyhippuric acid | ChEBI | Salicyloylglycine | ChEBI | Salicylurate | ChEBI | O-Hydroxyhippate | Generator | O-Hydroxyhippic acid | Generator | Salicylate | Generator | Salicylic acid | Generator | ((2-Hydroxybenzoyl)amino)acetic acid | HMDB | (2-Hydroxybenzoyl)glycine | HMDB | 2-Hydroxybenzoylaminoacetate | HMDB | 2-Hydroxybenzoylaminoacetic acid | HMDB | 2-Hydroxybenzoylglycine | HMDB | 2-Hydroxyhippurate | HMDB | 2-Hydroxyhippuric acid | HMDB | N-O-Hydroxybenzoylglycine | HMDB | O-Hydroxy-hippurate | HMDB | O-Hydroxy-hippuric acid | HMDB | O-Hydroxyhippurate | HMDB | Ortho-hydroxyhippurate | HMDB | Ortho-hydroxyhippuric acid | HMDB | Salicylglycine | HMDB | [(2-Hydroxybenzoyl)amino]acetate | HMDB | [(2-Hydroxybenzoyl)amino]acetic acid | HMDB | Salicylurate, monosodium salt | HMDB | N-(O-Hydroxybenzoyl)glycine | HMDB | 2-[(2-Hydroxybenzoyl)amino]acetic acid | HMDB | 2'-Hydroxyhippuric acid | HMDB | N-(2-Hydroxybenzoyl)glycine | MeSH, HMDB | Salicyluric acid | Generator | 2-(2-Hydroxybenzamido)acetic acid | |
|
---|
Chemical Formula | C9H9NO4 |
---|
Average Mass | 195.1721 Da |
---|
Monoisotopic Mass | 195.05316 Da |
---|
IUPAC Name | 2-[(2-hydroxyphenyl)formamido]acetic acid |
---|
Traditional Name | salicyluric acid |
---|
CAS Registry Number | 487-54-7 |
---|
SMILES | OC(=O)CNC(=O)C1=C(O)C=CC=C1 |
---|
InChI Identifier | InChI=1S/C9H9NO4/c11-7-4-2-1-3-6(7)9(14)10-5-8(12)13/h1-4,11H,5H2,(H,10,14)(H,12,13) |
---|
InChI Key | ONJSZLXSECQROL-UHFFFAOYSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Species Where Detected | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as hippuric acids. Hippuric acids are compounds containing hippuric acid, which consists of a of a benzoyl group linked to the N-terminal of a glycine. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Benzoic acids and derivatives |
---|
Direct Parent | Hippuric acids |
---|
Alternative Parents | |
---|
Substituents | - Hippuric acid
- N-acyl-alpha amino acid or derivatives
- N-acyl-alpha-amino acid
- Alpha-amino acid or derivatives
- Salicylic acid or derivatives
- Salicylamide
- Benzoyl
- 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Phenol
- Vinylogous acid
- Carboxamide group
- Secondary carboxylic acid amide
- Carboxylic acid derivative
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Organic nitrogen compound
- Organonitrogen compound
- Organooxygen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Carbonyl group
- Organic oxygen compound
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | 168 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 27180 mg/L @ 25 °C (est) | The Good Scents Company Information System | LogP | 0.95 | Hansch CH, Leo A and Hoekman DH. "Exploring QSAR: Hydrophobic, Electronic, and Steric Constraints. Volume 1" ACS Publications (1995). |
|
---|
Predicted Properties | |
---|
General References | - Buskin JN, Upton RA, Williams RL: Improved liquid-chromatography of aspirin, salicylate, and salicyluric acid in plasma, with a modification for determining aspirin metabolites in urine. Clin Chem. 1982 May;28(5):1200-3. [PubMed:7074905 ]
- Cham BE, Bochner F, Imhoff DM, Johns D, Rowland M: Simultaneous liquid-chromatographic quantitation of salicylic acid, salicyluric acid, and gentisic acid in urine. Clin Chem. 1980 Jan;26(1):111-4. [PubMed:7356541 ]
- Sakurai M, Ohsako M, Nagano M, Nakamura C, Tsuzuki O, Ichikawa M, Matsumoto Y: [Effect of human serum albumin on transport of drugs through human erythrocyte membranes]. Yakugaku Zasshi. 1996 Aug;116(8):630-8. [PubMed:8831264 ]
- Pirker R, Huck CW, Popp M, Bonn GK: Simultaneous determination of gentisic, salicyluric and salicylic acid in human plasma using solid-phase extraction, liquid chromatography and electrospray ionization mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Oct 5;809(2):257-64. [PubMed:15315774 ]
- Lares-Asseff I, Juarez-Olguin H, Flores-Perez J, Guille-Perez A, Vargas A: Pharmacokinetics and metabolic rates of acetyl salicylic acid and its metabolites in an Otomi ethnic group of Mexico. Biol Pharm Bull. 2004 May;27(5):706-9. [PubMed:15133250 ]
- Farid NA, Born GS, Kessler WV, Shaw SM, Lange WE: Improved colorimetric determination of salicylic acid and its metabolites in urine. Clin Chem. 1975 Jul;21(8):1167-8. [PubMed:1137922 ]
- Kershaw RA, Mays DC, Bianchine JR, Gerber N: Disposition of aspirin and its metabolites in the semen of man. J Clin Pharmacol. 1987 Apr;27(4):304-9. [PubMed:3680588 ]
- Lawrence JR, Peter R, Baxter GJ, Robson J, Graham AB, Paterson JR: Urinary excretion of salicyluric and salicylic acids by non-vegetarians, vegetarians, and patients taking low dose aspirin. J Clin Pathol. 2003 Sep;56(9):651-3. [PubMed:12944546 ]
- Arancibia JA, Olivieri AC, Escandar GM: First- and second-order multivariate calibration applied to biological samples: determination of anti-inflammatories in serum and urine. Anal Bioanal Chem. 2002 Oct;374(3):451-9. Epub 2002 Sep 11. [PubMed:12373394 ]
- Baxter GJ, Lawrence JR, Graham AB, Wiles D, Paterson JR: Identification and determination of salicylic acid and salicyluric acid in urine of people not taking salicylate drugs. Ann Clin Biochem. 2002 Jan;39(Pt 1):50-5. [PubMed:11853189 ]
- Day RO, Dromgoole SH, Furst DE, Hignite C, Paulus HE: Formation of methyl ester of salicyluric acid during quantitation of salicyluric acid in urine by high-pressure liquid chromatography. J Pharm Sci. 1981 Sep;70(9):1090-2. [PubMed:6101164 ]
- Olsson B: Decreasing serum salicylate concentrations during long-term administration of acetylsalicylic acid in healthy volunteers. Discussion of possible clinical implications. Scand J Rheumatol. 1983;12(2):81-4. [PubMed:6857178 ]
|
---|